India's Jubilant Ingrevia rises after USFDA inspection ends

Jubilant Ingrevia

28/06/2024 05:43

** Shares of Jubilant Ingrevia  JUBN.NS  rise as much as
2.4% to 529 rupees, last up 1%
    ** The specialty chemicals maker gets establishment
inspection report from U.S. Food and Drug Administration
(USFDA), concluded with zero 483 observations for its
manufacturing facility in Gujarat
    ** JUBN down ~2% so far this week, set to snap three-week
gaining streak
    ** Stock up ~3% YTD, had fallen 3.8% in 2023- its second
straight year of losses

 (Reporting by Dimpal Gulwani in Bengaluru)
 ((dimpal.gulwani@thomsonreuters.com))